| JYSB1900064 | Ramucirumab | ramucirumab | Injection | Biological Products | Supplementary Application | 2019-03-21 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2019-05-27 | view |
| JXHL0900204 | 盐酸Prasugrel | prasugrel hydrochloride | Active ingredient | Chemical Drugs | Import Drug Application | 2009-07-01 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2010-02-05 | view |
| JXHL1800175 | Baricitinib (LY3009104)片 | baricitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2018-12-06 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2018-12-05 | view |
| JXHL2100058 | Tirzepatide注射液 | tirzepatide | Injection | Chemical Drugs(1) | Import Drug Application | 2021-02-25 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2021-02-24 | view |
| JXHL1500090 | LY2157299 | galunisertib | Other | Chemical Drugs | Import Drug Application | 2015-04-30 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2015-12-31 | view |
| JXHL2000011 | 注射用培美曲塞二钠 | pemetrexed disodium | Lyophilized | Chemical Drugs(2.4) | Import Drug Application | 2020-02-15 | ELI LILLY AND COMPANY | Eli Lilly & Company | In Review | 2020-02-14 | view |
| JXSL1200032 | LY2127399注射液 | tabalumab | Injection | Biological Products | Import Drug Application | 2012-04-27 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2013-07-18 | view |
| JXHL1900071 | Tirzepatide注射液 | tirzepatide | Injection | Chemical Drugs(1) | Import Drug Application | 2019-04-10 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2019-04-09 | view |
| JYHB0900886 | LY450139 | semagacestat | Active ingredient | Chemical Drugs | Supplementary Application | 2009-10-13 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2010-06-04 | view |
| JXHL0800082 | 艾塞那肽长效缓释剂 | Exenatide | Other | Chemical Drugs | Import Drug Application | 2008-03-07 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2009-06-10 | view |
| JXHL1700014 | Baricitinib (LY3009104)片剂 | baricitinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2017-02-03 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2017-12-25 | view |
| JXHL2000201 | Tirzepatide注射液 | tirzepatide | Injection | Chemical Drugs(1) | Import Drug Application | 2020-07-06 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2020-07-04 | view |
| JXSL1300070 | Ramucirumab | ramucirumab | Injection | Biological Products | Import Drug Application | 2013-11-08 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2015-01-08 | view |
| JXHL1900298 | Tirzepatide注射液 | tirzepatide | Injection | Chemical Drugs(1) | Import Drug Application | 2019-11-09 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2019-11-08 | view |
| JYHB1000656 | 盐酸度洛西汀肠溶胶囊 | duloxetine hydrochloride | Capsule | Chemical Drugs | Supplementary Application | 2010-08-04 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2013-01-18 | view |
| JXHS0800068 | 盐酸度洛西汀肠溶胶囊 | duloxetine hydrochloride | Capsule | Chemical Drugs | Import Drug Application | 2008-12-02 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2009-10-21 | view |
| JXHL1800091 | Baricitinib (LY3009104)片 | baricitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2018-08-13 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2018-09-30 | view |
| JTS2000051 | Ramucirumab | ramucirumab | Injection | Biological Products | Disposable Import Drug Application | 2020-11-06 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2020-11-30 | view |
| JXHL1400265 | LY2157299 | galunisertib | Other | Chemical Drugs | Import Drug Application | 2014-07-31 | Eli Lilly and Company | Eli Lilly & Company | Certificate Issued | 2015-10-27 | view |
| JXHL1900365 | Tirzepatide注射液 | tirzepatide | Injection | Chemical Drugs(1) | Import Drug Application | 2019-12-28 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2019-12-27 | view |
